BeStock  

Clorox CLX

US equityMarket cap rank #1240Household & Personal Products
$104.73 −$0.17 (-0.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $104.58 -0.15%
Open$105.95
Prev close$104.90
Day range$104.68 – $107.81
Volume3.05M
Market cap$12.69B
P/E (TTM)18.9
Dividend yield4.75%

Earnings

Average move on report day±5.4%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+9.8%
Worst reaction-9.7%

Stock move on the day after each report

+5.6%2024/Q2-5.6%2024/Q3+7.4%2024/Q4+1.3%2025/Q1-7.2%2025/Q2-2.4%2025/Q3-2.0%2025/Q4+1.2%2026/Q1+2.4%2026/Q2-9.7%2026/Q3+6.5%2026/Q4+4.3%2027/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2027/Q12 Nov 2026After Market±6.3%+4.34%Within range
2026/Q43 Aug 2026After Market±6.3%+6.52%Bigger than priced
2026/Q330 Apr 2026After Market±5.3%-9.67%Bigger than priced
2026/Q23 Feb 2026After Market±4.4%+2.43%Within range
2026/Q13 Nov 2025After Market±5.4%+1.17%Within range
2025/Q431 Jul 2025After Market±7.7%-1.96%Within range
2025/Q35 May 2025After Market±6.5%-2.41%Within range
2025/Q23 Feb 2025After Market±6.7%-7.24%Bigger than priced
2025/Q130 Oct 2024After Market±6.2%+1.30%Within range
2024/Q41 Aug 2024After Market±6.8%+7.42%Bigger than priced
2024/Q330 Apr 2024After Market±5.0%-5.57%Bigger than priced
2024/Q21 Feb 2024After Market±5.6%+5.62%Within range
2024/Q11 Nov 2023After Market±5.8%+6.61%Bigger than priced
2023/Q42 Aug 2023After Market±4.6%+8.96%Bigger than priced
2023/Q32 May 2023After Market±4.8%+4.70%Within range
2023/Q22 Feb 2023After Market±5.4%+9.77%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2027/Q1

By business line

  • Health and wellness$918.00M 48.2%
  • Household$423.00M 22.2%
  • Lifestyle$283.00M 14.9%
  • International$281.00M 14.8%

Latest reported quarter: Q1, ended Sep 2026

Revenue$1.91B+33.3% YoY
Operating profit$249.00M+107.5% YoY
Net profit$173.00M+111.0% YoY
Diluted EPS$1.39+113.8% YoY
Free cash flow$105.00M+84.2% YoY
Operating cash flow$143.00M

Revenue, last 8 quarters

$1.7BDec '24$1.7BMar '25$2.0BJun '25$1.4BSep '25$1.7BDec '25$1.7BMar '26$1.9BJun '26$1.9BSep '26

Net profit, last 8 quarters

$194.0MDec '24$191.0MMar '25$336.0MJun '25$82.0MSep '25$161.0MDec '25$191.0MMar '26$167.0MJun '26$173.0MSep '26

Profitability & balance sheet

Gross margin41.9%
Operating margin14.1%
Net margin9.4%
Return on assets10.1%
Current ratio0.65
Liabilities / assets98.5%
Cash & investments$184.00M
Total debt$5.51B
Net cash (debt)-$5.32B
Free cash flow / sales6.3%

Discussion

No comments yet — be the first to weigh in on CLX.

Sign in to join the discussion.

Scroll to Top